DA
PFE icon

DSC Advisors’s Pfizer PFE Stock Holding History

DSC Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,712
Closed -$294K – 72
2022
Q3 		$294K Sell
6,712
-3,092
-32% -$150K 0.3% 64
2022
Q2 		$514K Sell
9,804
-297
-3% -$15.1K 0.51% 34
2022
Q1 		$523K Buy
10,101
+5,437
+117% +$282K 0.18% 49
2021
Q4 		$275K Sell
4,664
-148
-3% -$7.33K 0.21% 58
2021
Q3 		$207K Buy
+4,812
New +$213K 0.21% 69
2020
Q1 		– Sell
-5,629
Closed -$209K – 67
2019
Q4 		$209K Buy
+5,629
New +$201K 0.1% 79
2019
Q1 		– Sell
-5,279
Closed -$219K – 86
2018
Q4 		$219K Buy
+5,279
New +$219K 0.03% 66

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DSC Advisors's PFE Position: Q4 2022 in Review

DSC Advisors sold out of Pfizer (PFE) in Q4 2022, closing a stake of 6,712 shares — an estimated $294K sold.

DSC Advisors first reported a position in PFE in Q4 2018 and held it in 7 quarters. The position peaked at $523K in Q1 2022. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • DSC Advisors reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • DSC Advisors sold 6,712 Pfizer shares in Q4 2022, an estimated $294K.
  • DSC Advisors first reported a position in Pfizer in Q4 2018 and held it in 7 quarters.
  • DSC Advisors's Pfizer position peaked at $523K in Q1 2022.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on DSC Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.